Tech Network Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Network Grenada.

Press releases published on July 8, 2026

Jul. 8, 2026

Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026

Indeterminate GlobeNewswire

Jul. 8, 2026

FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months

Indeterminate GlobeNewswire

Jul. 8, 2026

Quantum Cyber Completes Confidential Submission to U.S. Army Program

Indeterminate GlobeNewswire

Jul. 8, 2026

Odysight.ai Receives Purchase Order from Elbit Systems on Behalf of the Israeli Ministry of Defense for Deployment of Its Vision-Based Prognostics and Health Management System

Indeterminate GlobeNewswire

Jul. 8, 2026

BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities

Indeterminate GlobeNewswire

Jul. 8, 2026

Microchip Expands Developer Access with Free MPLAB® XC Compilers and MPLAB Machine Learning Development Suite

Indeterminate GlobeNewswire

Jul. 8, 2026

Upfront Diagnostics Announces Global Medical Advisory Board to Accelerate Efforts in Reducing Time to Stroke Care

Indeterminate GlobeNewswire

Jul. 8, 2026

Shopify to Announce Second-Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 8, 2026

Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment

Indeterminate GlobeNewswire

Jul. 8, 2026

Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees

Indeterminate GlobeNewswire

Jul. 8, 2026

OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain

Indeterminate GlobeNewswire

Jul. 8, 2026

Virtune lists the Virtune Hyperliquid ETP on Nasdaq Stockholm and Nasdaq Helsinki

Indeterminate GlobeNewswire

Jul. 8, 2026

Virtune listaa Virtune Hyperliquid ETP:n Nasdaq Tukholmaan ja Nasdaq Helsinkiin

Indeterminate GlobeNewswire

Jul. 8, 2026

UK businesses drastically overestimate their AI progress

Indeterminate GlobeNewswire

Jul. 8, 2026

Herstel is de benchmark van veerkracht

Indeterminate GlobeNewswire

Jul. 8, 2026

AMSilk and Ajinomoto Foods Europe Expand Partnership to Enable Industrial-Scale Production of Silk Proteins

Indeterminate GlobeNewswire

Jul. 8, 2026

The Board Decision Gap: AI Transforms the Deal, But Boards Still Govern the Outcome

Indeterminate GlobeNewswire

Jul. 8, 2026

Snail Games 推出《方舟：創世崛起》第一部分、《方舟：財富之潮》及《方舟：龍之烏托邦》可下載內容；遞延收入積壓中的 1,100 萬美元將於 2026 年第三季度確認

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical conclut un accord avec Novo Nordisk pour évaluer le NPM-139, un implant miniature à base de sémaglutide à action ultra-prolongée destiné au traitement de l’obésité

Indeterminate GlobeNewswire

Jul. 8, 2026

ヴィヴァニ・メディカル、慢性体重管理のためのセマグルチドの超長時間作用小型インプラント「NPM-139」の評価に向け、ノボ ノルディスクと契約を締結

Indeterminate GlobeNewswire